In which patient population is ketamine preferred for use?

Ketamine is preferred for use in asthmatic patients primarily due to its bronchodilatory properties. When ketamine is administered, it can lead to relaxation of the bronchial smooth muscle, making it beneficial for patients experiencing bronchospasm, which is common in asthma. This makes it a safe and effective option for managing sedation or analgesia in these patients without exacerbating their respiratory condition.

In addition to its bronchodilator effects, ketamine provides analgesia and sedation without significantly suppressing respiratory drive, which is particularly advantageous in individuals with a history of asthma. The safety profile and the ability to maintain airway reflexes while also delivering sedation make ketamine a strong choice in emergencies involving asthmatic patients.

While ketamine can be used in various populations, such as pediatrics, its unique benefits in the context of bronchospasm and asthma make it especially favored in that setting. Other populations mentioned may require different considerations regarding the pharmacodynamics and the potential effects on cardiovascular or respiratory systems.